Recently, significant gains have been made in the care of the patient allergic to stinging insects. Though epinephrine continues to be the drug of choice for the management of the anaphylactic reaction, newer delivery systems allow self-administration of the drug immediately following a sting to abort or attenuate a subsequent reaction. Patients most at risk, those with a history of life-threatening episodes of anaphylaxis following a sting, can be diagnosed and treated with the recently released Hymenoptera venoms with the expectation of excellent results. This success, however, has been accompanied by the frustration of not knowing the natural course of the disease in sufficient detail to counsel in cases of less dramatic insect hypersensitivity.
最近，在对蜇人昆虫过敏患者的护理方面取得了显著进展。尽管肾上腺素仍然是治疗过敏反应的首选药物，但新型给药系统使患者在被蜇后能立即自行给药，以中止或减轻后续反应。风险最高的患者，即那些有蜇伤后发生危及生命的过敏反应病史的患者，可以使用最近上市的膜翅目昆虫毒液进行诊断和治疗，有望取得良好效果。然而，这一成功也伴随着一种无奈，即对于症状不那么严重的昆虫过敏病例，由于对疾病的自然病程了解不够详细，无法提供充分的咨询建议。
Zotero 插件